Clinical Trials Browser

Phase 2 × Pharmaceutical Preparations × Thoracic × Clear all

NCT04318938 2026-03-02

Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping

Phase 2 Active not recruiting

NSCLC

NCT00285675 2006-05-31

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Phase 2 Unknown

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms